Life Sciences: CDPQ invests in Amplitude
Caisse de dépôt et placement du Québec (CDPQ) announced an investment in Amplitude, a Québec life sciences fund that finances and supports biotech, medical device and health information technology start-ups.
Earlier today, Amplitude announced that it had obtained over 50% of its financing target for its new $200 million fund. CDPQ joins BDC Capital, Fonds de solidarité FTQ, Teralys and Investissement Québec in participating in this first closing.
“This investment aligns with our commitment to support companies operating in life sciences, which is a growing sector of our innovation economy,” said Charles Emond, Executive Vice-President and Head of Québec Investments and Global Strategic Planning at CDPQ. “With the progress in recent years on data analysis and new technology integration, new medical treatments are developing at a rapid pace. Amplitude is well positioned to benefit from this transformation and support the companies that will stand out.”
falsefalsePleine largeurfalse
In addition to Amplitude, CDPQ is already active in other life sciences funds such as CTI Life Sciences Fund, Lumira Ventures and Versant Ventures.
Transaction details are set out in a news release published by Amplitude.
ABOUT CAISSE DE DÉPÔT ET PLACEMENT DU QUÉBEC
Caisse de dépôt et placement du Québec (CDPQ) is a long-term institutional investor that manages funds primarily for public and parapublic pension and insurance plans. As at June 30, 2019, it held CA$326.7 billion in net assets. As one of Canada's leading institutional fund managers, CDPQ invests globally in major financial markets, private equity, infrastructure, real estate and private debt. For more information, visit cdpq.com, follow us on Twitter @LaCDPQ or consult our Facebook or LinkedIn pages.
- 30 -